Home About us Contact
|
Home About us Contact | ||
|
|
||
pHi Recovery (phi + recovery)
Selected AbstractsCell shrinkage evoked by Ca2+ -free solution in rat alveolar type II cells: Ca2+ regulation of Na+,H+ exchangeEXPERIMENTAL PHYSIOLOGY, Issue 2 2005Hitoshi Murao The effects of intracellular Ca2+ concentration, [Ca2+]i, on the volume of rat alveolar type II cells (AT-II cells) were examined. Perfusion with a Ca2+ -free solution induced shrinkage of the AT-II cell volume in the absence or presence of amiloride (1 ,m, an inhibitor of Na+ channels); however, it did not in the presence of 5-(N -methyl- N -isobutyl)-amiloride (MIA, an inhibitor of Na+,H+ exchange). MIA decreased the volume of AT-II cells. Inhibitors of Cl,,HCO3, exchange, 4,4,-diisothiocyanostilbene-2,2,-disulfonic acid (DIDS) and 4-acetamido-4,-isothiocyanatostilbene-2,2,-disulfonic acid (SITS) also decreased the volume of AT-II cells. This indicates that the cell shrinkage induced by a Ca2+ -free solution is caused by a decrease in NaCl influx via Na+,H+ exchange and Cl,,HCO3, exchange. Addition of ionomycin (1 ,m), in contrast, induced cell swelling when AT-II cells were pretreated with quinine and amiloride. This swelling of the AT-II cells is not detected in the presence of MIA. Intracellular pH (pHi) measurements demonstrated that the Ca2+ -free solution or MIA decreases pHi, and that ionomycin increases it. Ionomycin stimulated the pHi recovery after an acid loading (NH4+ pulse method), which was not noted in MIA-treated AT-II cells. Ionomycin increased [Ca2+]i in fura-2-loaded AT-II cells. In conclusion, the Na+,H+ exchange activities of AT-II cells, which maintain the volume and pHi, are regulated by [Ca2+]i. [source] Modulation of Na+ -H+ exchange isoforms NHE1 and NHE3 by insulin-like growth factor-1 in isolated bovine articular chondrocytesJOURNAL OF ORTHOPAEDIC RESEARCH, Issue 11 2008Amanda L. Tattersall Abstract Incubation with serum modulates the transporters that regulate intracellular pH (pHi) in articular chondrocytes, upregulating acid extrusion by Na+ -H+ exchange (NHE). There is stimulation of NHE1, together with induction of NHE3 activity. These isoforms exhibit differential responses to components of mechanical load experienced by chondrocytes during joint loading. The identity of the component(s) of serum responsible is unknown. A possibility, however, is insulin-like growth factor-1 (IGF-1), present in normal cartilage and found at enhanced levels in osteoarthritic tissue. In the present study, the effects of IGF-1 on pHi regulation have been characterized using fluorescence measurements of bovine articular chondrocytes, and the sensitivity of pHi regulation to hyperosmotic shock and raised hydrostatic pressure determined. For cells isolated in the absence of IGF-1, pHi recovery following acidification was predominantly mediated by NHE1. Recovery was enhanced when cells were incubated for 18 h with 20 ng mL,1 IGF; this effect represented increased acid extrusion by NHE1, supplemented by NHE3 activity. NHE3 activity was not detected in IGF-1-treated cells that had been incubated with the protein synthesis inhibitor cycloheximide, although NHE1 activity was unaffected. In the absence of IGF-1, suspension in hyperosmotic solutions or raised hydrostatic pressure enhanced pHi recovery of acidified cells. This response was missing in cells incubated with IGF-1. Unresponsiveness to hyperosmotic shock represented inhibition of NHE3 activity, and was prevented using the protein kinase A inhibitor KT5720. For raised hydrostatic pressure, a decrease in NHE1 activity was responsible, and was prevented by the protein kinase C inhibitor chelerythrine. © 2008 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 26:1428,1433, 2008 [source] Docosahexaenoic acid and other fatty acids induce a decrease in pHi in Jurkat T-cellsBRITISH JOURNAL OF PHARMACOLOGY, Issue 7 2003Virginie Aires Docosahexaenoic acid (DHA) induced rapid (t1/2=33 s) and dose-dependent decreases in pHi in BCECF-loaded human (Jurkat) T-cells. Addition of 5-(N,N -dimethyl)-amiloride, an inhibitor of Na+/H+ exchanger, prolonged DHA-induced acidification as a function of time, indicating that the exchanger is implicated in pHi recovery. Other fatty acids like oleic acid, arachidonic acid, eicosapentaenoic acid, but not palmitic acid, also induced a fall in pHi in these cells. To assess the role of calcium in the DHA-induced acidification, we conducted experiments in Ca2+ -free (0% Ca2+) and Ca2+ -containing (100% Ca2+) buffer. We observed that there was no difference in the degree of DHA-induced transient acidification in both the experimental conditions, though pHi recovery was faster in 0% Ca2+ medium than that in 100% Ca2+ medium. In the presence of BAPTA, a calcium chelator, a rapid recovery of DHA-induced acidosis was observed. Furthermore, addition of CaCl2 into 0% Ca2+ medium curtailed DHA-evoked rapid pHi recovery. In 0% Ca2+ medium, containing BAPTA, DHA did not evoke increases in [Ca2+]i, though this fatty acid still induced a rapid acidification in these cells. These observations suggest that calcium is implicated in the long-lasting DHA-induced acidosis. DHA-induced rapid acidification may be due to its deprotonation in the plasma membrane (flip-flop model), as suggested by the following observations: (1) DHA with a ,COOH group induced intracellular acidification, but this fatty acid with a ,COOCH3 group failed to do so, and (2) DHA, but not propionic acid, -induced acidification was completely reversed by addition of fatty acid-free bovine serum albumin in these cells. These results suggest that DHA induces acidosis via deprotonation and Ca2+ mobilization in human T-cells. British Journal of Pharmacology (2003) 140, 1217,1226. doi:10.1038/sj.bjp.0705563 [source] Pharmacological profile of SL 59.1227, a novel inhibitor of the sodium/hydrogen exchangerBRITISH JOURNAL OF PHARMACOLOGY, Issue 6 2000Janine Lorrain The NHE1 isoform of the Na+/H+ exchanger plays an important role in the regulation of intracellular pH and in cardiac cell injury caused by ischaemia and reperfusion. SL 59.1227 is a novel imidazolypiperidine Na+/H+ antiport inhibitor which is structurally unrelated to previously described acylguanidine inhibitors such as cariporide. Recovery of pHi following an intracellular acid load was measured in CCL39-derived PS120 variant cells, selectively expressing either NHE1 or NHE2 isoforms of the Na+/H+ exchanger. pHi recovery was potently and selectively slowed by SL 59.1227 in NHE1-expressing cells (IC50 3.3±1.3 nM) versus NHE2-expressing cells (2.3±1.0 ,M). The respective IC50 values for cariporide were 103±28 nM (NHE1) and 73±46 ,M (NHE2). In anaesthetized rats following left coronary artery occlusion (7 min) and reperfusion (10 min) SL 59.1227 (10,100 ,g kg,1 min,1 i.v.) inhibited ischaemia-mediated ventricular tachycardia (71,100%) and reperfusion-induced ventricular fibrillation (75,87%) and prevented mortality. Bolus i.v. administration of SL 59.1227 (1 mg kg,1) produced anti-arrhythmic effects when administered either before or during ischaemia. Cardiac infarct size was determined in anaesthetized rabbits following left coronary artery occlusion (30 min) and reperfusion (120 min). Infarct size measured as a percentage of the area at risk was 36.2±3.4% (control group) versus 15.3±3.9% (SL 59.1227 0.6 mg kg,1 i.v.). SL 59.1227 is the first example of a potent and NHE1-selective non-acylguanidine Na+/H+ exchanger inhibitor. It possesses marked cardioprotective properties. British Journal of Pharmacology (2000) 131, 1188,1194; doi:10.1038/sj.bjp.0703671 [source] | ||||||||||